Doctors test if risky drugs can be safely stopped for kidney failure patients

NCT ID NCT03323476

Ongoing Disease control Sponsor: Centre Hospitalier Departemental Vendee Source: ClinicalTrials.gov ↗

Summary

This study aims to find out if it's safe to stop long-term immune-suppressing drugs in patients with ANCA vasculitis who have developed total kidney failure. Researchers will compare patients who stop the drugs to those who continue them, checking for severe infections, disease flare-ups, or death over two years. The goal is to see if stopping treatment reduces serious side effects without increasing the risk of the disease coming back outside the kidneys.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

APHP - Henri Mondor

Paris, France
APHP Ambroise Paré

Boulogne-Billancourt, France
AUB Santé

Avranches, France
AUB Santé - Lorient

Lorient, France
AUB Santé - Rennes

Rennes, France
Aphp - Bichat

Paris, France
Aphp - Hegp

Paris, France
CHI Eure Seine

Évreux, France
CHRU Besançon

Besançon, France
CHRU Bretonneau

Tours, France
CHRU Lille

Lille, France
CHU Angers

Angers, France
CHU Kremlin - Bicêtre

Paris, France
CHU Toulouse

Toulouse, France
CHU de Nimes

Nîmes, France
Centre ECHO - Le Mans

Le Mans, France
Centre Hospitalier ARRAS

Arras, France
Centre Hospitalier Alpes Léman

Sallanches, France
Centre Hospitalier Angoulême

Angoulême, France
Centre Hospitalier Avignon

Avignon, France
Centre Hospitalier Boulogne sur Mer

Boulogne-sur-Mer, France
Centre Hospitalier Bretagne Atlantique

Vannes, France
Centre Hospitalier Chartres

Chartres, France
Centre Hospitalier Départemental Vendée

La Roche-sur-Yon, 85925, France
Centre Hospitalier Emile ROUX

Le Puy-en-Velay, France
Centre Hospitalier La Rochelle

La Rochelle, France
Centre Hospitalier Le Mans

Le Mans, France
Centre Hospitalier Lyon Sud

Lyon, France
Centre Hospitalier Quimper

Quimper, France
Centre Hospitalier René Dubois - Pontoise

Cergy-Pontoise, France
Centre Hospitalier Saint Brieuc

Saint-Brieuc, France
Centre Hospitalier Saint-Malo

St-Malo, France
Centre Hospitalier Saint-Nazaire

Saint-Nazaire, France
Centre Hospitalier Universitaire Amiens

Amiens, France
Centre Hospitalier Universitaire Bordeaux

Bordeaux, France
Centre Hospitalier Universitaire Dupuytren

Limoges, France
Centre Hospitalier Universitaire G. Montpied

Clermont-Ferrand, France
Centre Hospitalier Universitaire Grenoble

Grenoble, France
Centre Hospitalier Universitaire Lapeyronie

Montpellier, France
Centre Hospitalier Universitaire Nice

Nice, France
Centre Hospitalier Universitaire Poitiers

Poitiers, France
Centre Hospitalier Universitaire Rennes

Rennes, France
Centre Hospitalier Universitaire Rouen

Rouen, France
Centre Hospitalier Universitaire Saint Etienne

Saint-Etienne, France
Centre Hospitalier Universitaire Strasbourg

Strasbourg, France
Centre Hospitalier Universitaire de Brest

Brest, France
Centre Hospitalier Universitaire de Dijon

Dijon, France
Centre Hospitalier Universitaire de Nantes

Nantes, France
Centre Hospitalier Valenciennes

Valenciennes, France
Centre Hospitalier de Mont de Marsan

Mont-de-Marsan, France
Clinique Saint Exupéry

Toulouse, France
GHR Mulhouse Sud Alsace

Mulhouse, France
Hopital Louis Pasteur

Colmar, France
Hopital de la Conception - APHM

Marseille, France
Hôpital Privé La Louvière

Lille, 59042, France
Hôpital Saint Louis

Paris, France
Hôpital Tenon

Paris, France

Conditions

Explore the condition pages connected to this study.

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS END STAGE RENAL DISEASE